Direct labeling studies of octapeptides with rhenium-188

Radiochimica Acta

Volumn 91, Issue 7, 2003, Pages 427-432

  Faintuch, B L ^a   Pereira, N P S ^a   Faintuch, S ^b   Muramoto, E ^a   Silva, C P G ^a  

^a INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Lanreotide; Octreotide; Radiopharmaceuticals; Rhenium 188

Indexed keywords

ANGIOPEPTIN; CYSTEINE; OCTAPEPTIDE; OCTREOTIDE; RHENIUM 188; STANNOUS CHLORIDE;

ARTICLE; CHELATION; GASTROINTESTINAL TRACT; ISOTOPE LABELING; KIDNEY; PLASMA CLEARANCE; RADIOCHEMISTRY;

EID: 0038375815     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.91.7.427.20013     Document Type: Article

References (18)

1. De Jong, M., Bakker, W. H., Breeman, W. A., Bernard, B. F., Hofland, D. J., Visser, T. J., Srunivasan, A., Schmidt, M., Behe, M., Macke, H. R., Krenning, E. P.: Pre-clinical comparison of [DTPA]-octreotide, [DTPA, Tyr]Octreotide and [DOTA, Tyr]octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int. J. Cancer 75, 406 (1998).
2. Wessels, B. W., Rogus, R. D.: Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies. Med. Phys. 11, 638 (1984).
3. Griffiths, G. L., Goldenberg, D. M., Knapp, Jr., F. F., Callahan, A. P., Chang, C. H., Hansen, H. J.: Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Cancer Res. 51, 4594 (1991).
4. 188Re-RC-160, a somatostatin analogue. Tumor Targeting 2, 49 (1996).
5. 99mTc-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer. J. Nucl. Med. 36, 430 (1995).
6. Lamberts, S. W., Krenning, E. P., Reubi, J. C.: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12, 450 (1992).
7. Smith-Jones, P. M., Bischof, C., Lleimer, M., Gludovacz, D., Angelberger, P., Pangerl, T., Peck-Radosavljevic, M., Hamilton, G., Kasererk, C., Kofler, A.,Schlengbauer-Wadl, H., Traub, T., Virgolini, I.: DOTA-lanreotide: A novel somatostatin analog for tumor diagnosis and therapy, Endocrinology 140, 5136 (1999).
8. Arnold, R., Simon, B., Wied, M.: Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review. Digestion 62, Suppl. 1, 84 (2000).
9. Virgolini, I., Szilvasi, I., Smith-Jones, P., Angelberger, P., Kurtaran, A.: "MAURITIUS": Animal and human distribution and tumour localization. Eur. J. Nucl. Med. 24, 874 (1997).
10. 188Re-β-naphthyl-peptide in cervical carcinoma tumours in athymic mice. Nucl. Med. Comm. 28, 319 (2001).
11. Krenning, E. P., Bakker, W. H., Breeman, W. A.: Localization of endocrine-related tumours with raidoiodinated analogue of somatostatin. Lancet 1, 242 (1989).
12. 111In-DTPA-Octreotide. Peptide Res. 9, 3, 144 (1996).
13. 188Re-Direct labeling of monoclonal antibodies for radioimmunotherapy of solid tumors: Biodistribution, normal organ dosimetry, and toxicology. Nucl. Med. Biol. 25, 441 (1998).
14. 188Re-RC-160 Somatostatin analog: a peptide for local/regional radiotherapy. Appl. Radiat. Isot. 48, 3, 305 (1997).
15. 99mTc-labelling of proteins and peptides: factors that alter radiochemical yields and in vivo stability. In: Technetium, Rhenium and others Metals in Chemistry and Nuclear Medicine. (Nicolini, M., Mazzi, U., eds.) Padova, Italy (1995) pp. 281-286.
16. 188Re-lanreotide peptide and its quality control. Radiochim. Acta 88, 495 (2000).
17. Dadachova, E., Mirzadeh, S.: The role of tin in the direct labeling of proteins with rhenium-188. Nucl. Med. Biol. 24, 6, 605 (1997).
18. Cooper, A. J. L.: Biochemistry of sulfur-containing amino acids. A. Rev. Biochem. 52, 187 (1983).